Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism

OBJECTIVE: Increased hepatic de novo lipogenesis (DNL) is suggested to be an underlying cause in the development of nonalcoholic fatty liver disease and/or insulin resistance. It is suggested that omega-3 fatty acids (FA) lower hepatic DNL. We investigated the effects of omega-3 FA supplementation o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Open Diabetes Res Care
Hlavní autoři: Green, Charlotte J, Pramfalk, Camilla, Charlton, Catriona A, Gunn, Pippa J, Cornfield, Thomas, Pavlides, Michael, Karpe, Fredrik, Hodson, Leanne
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2020
Témata:
Metabolism
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7078804/
https://ncbi.nlm.nih.gov/pubmed/32188593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-000871
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky